Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective immunodepletion of endogenous stem cell niche for engraftment

Selective immunodepletion of endogenous stem cell niche for engraftment

US Patent 10072091 · Granted Sep 11, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-mediated conditioning with immunosuppression to enable allogeneic trans2025
Driving trip and pattern analysis2025
CD47 targeted therapies for the treatment of infectious disease2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
High affinity SIRP-alpha reagents and methods of using2025
Methods for manipulating phagocytosis mediated by CD472024